• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » ConsumerLab.com: Guiding Patients Toward OTCs That Won’t Hurt Them

ConsumerLab.com: Guiding Patients Toward OTCs That Won’t Hurt Them

July 1, 2017
Richard Gardiner, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Richard Gardiner, MD Psychiatrist in private practice in Potter Valley, CA Dr. Gardiner has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
“It’s rare that my patients don’t at some point or another try an over-the-counter sleep aid, anxiety preparation, or antidepressant supplement,” says TCPR board member Richard Gardiner, MD, who practices psychiatry in Mendocino County, California. While supplements may be helpful—we covered this topic in TCPR’s November/December 2016 issue—the FDA does not test them for purity or efficacy. For this reason, Gardiner often steers patients to ConsumerLab.com (CL).

CL was started by physician Tod Cooperman in 1999 along with FDA scientist Dr. William Obermeyer. The company’s mission is “to identify the best-quality health and nutritional products through independent testing.” CL purchases health products from retail stores and submits them to third-party laboratories. The goal is to compare different branded versions of a product, then report which ones passed—and which ones failed—the company’s quality tests. To date, CL has tested more than 4,400 products, including everything from black cohosh to valerian. In its report on valerian, for instance, it points out that two of the products tested contained lead, and that the amount of active ingredient in the supplements varied by more than 7-fold. Similar to Consumer Reports, CL publishes tables reviewing the major brands side by side, comparing the accuracy of the labels as well as relative cost.

Dr. Gardiner recommends the site to patients to “try to stop them from hurting themselves with mislabeled products or wasting their money” and to help determine whether a supplement might interfere with a medication he is prescribing. “If someone’s taking valerian and I’m giving them a sleeping pill and they’re now sleeping all day, is it because they are overdosing?” he asks as an example. The information on the site helps him and his patients find out.

A 12-month subscription to CL costs $39; a 24-month subscription costs $64. You can also sign up for a free one-day trial to read some sample reviews.
General Psychiatry
KEYWORDS anxiety_disorder natural_medications practice-tools-and-tips
Richard Gardiner, MD

More from this author
www.thecarlatreport.com
Issue Date: July 1, 2017
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Antidepressants, TCPR, July/August 2017
Beginning Antidepressant Treatment: A Recommended Approach
When First-Line Depression Treatments Don’t Cut It: Newer Antidepressants and Sometimes, Antipsychotics
When Depression Meds Fail, Transcranial Magnetic Stimulation Might Be Plan B
ConsumerLab.com: Guiding Patients Toward OTCs That Won’t Hurt Them
NeuroStar’s Latest TMS System: 19 Minutes Is the New 40
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.